# IMBRUVICA
> **NDA210563** · New Drug Application · Sponsor: PHARMACYCLICS LLC · Approved 2018-02-16
## Drug
- **FDA Application Number:** NDA210563
- **Application type:** New Drug Application
- **Brand name:** IMBRUVICA
- **Generic name:** IBRUTINIB
- **Active ingredients:** IBRUTINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PHARMACYCLICS LLC
- **Manufacturer:** Pharmacyclics LLC
- **First approval:** 2018-02-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210563)
---
*AI Analytics · CC0 1.0*